FTH
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. (FTH) has 2 SEC Form 4 filings (11 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 24, 2026.
Insiders have net bought $461K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Anand Parikh
- Employees:29
- HQ:Rockville, MD, US
- IPO:2014-08-11
Insider Buying
$461K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 8,183 | $181K | Jun 24 | SEC ↗ |
STEPHENSON BRIAN CFirst filing | Chief Financial Officer | Purchase | 9,230 | $225K | Jun 24 | SEC ↗ |
Parikh Anand KiranFirst filing | President and CEO | Purchase | 2,806 | $55K | Jun 24 | SEC ↗ |
Related companies
Faeth Therapeutics, Inc. is in the Healthcare sector.